New era for ME/CFS research as top cytokine study attracts media headlines
The immune systems of patients who have recently developed ME/CFS look markedly different from those who have been ill for much longer, according to a major new study from Drs. Ian Lipkin and Mady Hornig at Columbia University. This shift in immune function hadn’t been seen before.
Discuss the article on the Forums.

Prostate Cancer Vaccines Extend Lives

Discussion in 'Other Health News and Research' started by Rosemary, Jun 18, 2010.

  1. Rosemary

    Rosemary Senior Member

    Messages:
    193
    Likes:
    0
    Prostate Cancer Vaccines Extend Lives

    BOSTON, Mass. (Ivanhoe Newswire) -- The first FDA approved vaccine to treat prostate cancer is now available to patients. A second one is also in development. Doctors say the vaccines are changing the way they treat cancer. They're not cure-alls, but they could extend the lives of men who were only given a few years.

    We are not talking about vaccines in the sense of preventing a virus like polio, but we are talking about therapeutic vaccines that treat cancer by revving up the immune system, in some way, to try to fight the cancer, Philip Kantoff, M.D.,
    chief clinical research officer, at Dana Farber Cancer Institute, in Boston, Mass., told Ivanhoe.

    It doesn't prevent or cure cancer, but it is extending lives. In three-year study, 30 percent of patients who got the vaccine were alive - versus 17 percent who got a placebo shot. A second prostate cancer vaccine -- made from a patient's own cells -- is now FDA approved. It improved three-year survival by 38 percent.

    http://ivanhoe.com/channels/p_channelstory.cfm?storyid=24347

    The manufacturer of the FDA approved vaccine is charging $93,000 dollars for the treatment. It's covered by insurance, but doctors worry it could raise out of pocket costs for patients. A recent study found nearly 30 percent of cancer patients with $500 or more a year in out of pocket costs stopped filling their prescriptions.
     
  2. worshiper

    worshiper Guest

    I see the link.Well I have also heard about this.Cleveland researchers have developed a vaccine for prophylaxis of α-lactalbumin based think they could protect women against breast cancer tissue damage without inducing autoimmune reactions. The researchers are women over age 40 consider their target group.
     
  3. Snow Leopard

    Snow Leopard Senior Member

    Messages:
    2,681
    Likes:
    2,705
    Australia
    How exactly does this vaccine work?
    I'm a bit skeptical about vaccines that cost $93,000 ;)
     

See more popular forum discussions.

Share This Page